No Data
Earnings Call Summary | Catalyst Pharmaceuticals(CPRX.US) Q2 2024 Earnings Conference
Express News | Catalyst Pharmaceuticals Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results
Catalyst Pharmaceuticals, Inc. (CPRX) Q2 2024 Earnings Call Transcript
Express News | Catalyst Pharmaceuticals Inc : Piper Sandler Raises Target Price to $27 From $26
Catalyst Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Earnings Flash (CPRX) CATALYST PHARMACEUTICALS Reports Q2 Revenue $122.7M, Vs. Street Est of $111.9M